Leveraging her scientific experience, Natalie works with clients in the biotechnology and pharmaceutical sectors to develop and execute global patent prosecution strategies and manage complex patent portfolios. Her practice supports patent strategy throughout a product’s development and commercial launch, including patentability and landscape analyses, drafting and prosecuting patent applications, and advising on Orange Book and Patent Term Extension considerations.

Natalie received her Ph.D. in Biological and Biomedical Sciences from Harvard University, where she conducted research in cancer cell biology. Her doctoral studies focused on the role of the protein YAP1 in the regulation of epithelial cell morphology, adhesion, and migration, using a broad range of molecular, cellular, and microscopy techniques. She also gained experience with model organisms through her research in yeast genetics during her undergraduate education. Natalie has presented her work at local and national conferences and has co-authored peer-reviewed articles in journals including Cell.